Gloria Hamada alias The Biomarker Baron
moving supplement units at Hamada Health
Website · hamadahealth.com
Funnel-first framing that runs on persuasion, light on published evidence.
Oh, look at Gloria Hamada, the Functional Medicine Wizard who 'finds the root cause' of your diabetes and autoimmune disease with a DC license! She's the queen of the cash-only grift, selling you 'specialty' labs and her own online dispensary supplements while claiming insurance is the enemy of your health. She's not a doctor, but she's definitely a doctor of profit.
High grift signals
Score breakdown
Direct answer
Gloria Hamada is licensed in Unknown (General Chiropractic Standards) as a chiropractor (DC), not as an MD or DO, and Unknown (General Chiropractic Standards)'s chiropractic scope statute (63 P.S. § 601-§ 627 (Chiropractic Practice Act, as summarized by FCLB)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Autoimmune disease, Diabetes, Digestive issues & leaky gut, Cardiovascular, and Fatigue, conditions that belong with rheumatologists and gastroenterologists. Those same pages route patients toward supplements, lab panels, and paid programs that Gloria Hamada profits from.
Key findings
- False Authority: A chiropractor (DC) uses the title 'Dr.' and 'Functional Medicine Certified Practitioner' to imply broad medical authority equivalent to an MD/DO, despite their license being limited to musculoskeletal care.see section ↓
- Claim "autoimmune diseases": mixed in the medical literature.see section ↓
- Claim "Diabetes": mixed in the medical literature.see section ↓
- Gloria Hamada shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Gloria Hamada is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against state chiropractic licensing board scope rules (63 P.S. § 601-§ 627 (Chiropractic Practice Act, as summarized by FCLB)), these advertised activities appear outside Gloria Hamada's license (including conditions they merely list as ones they treat): Autoimmune disease, Diabetes, Digestive…see section ↓
- 12 of 14 advertised activities fall outside permitted Chiropractor scope in UNKNOWN.see section ↓
- Gloria Hamada dispenses specific medical advice while hiding behind a buried fine-print disclaimer to shield advice that is itself outside their licensed scope.see section ↓
Claims & evidence
9 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Gloria Hamada is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Autoimmune disease.
Autoimmune disease
- Supports
- High-quality reviews define autoimmune diseases as conditions where the immune system inappropriately targets the body’s own cells and tissues, often via autoreactive T and B cells and pathogenic autoantibodies, leading to chronic inflammation and organ dysfunction.[1][2][3][4][5][6][14][20][21] Large epidemiologic analyses and reviews indicate that there are more than 80–100 distinct autoimmune diseases, with common examples including type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, psoriasis, celiac disease, autoimmune thyroid disease, inflammatory bowel disease, Sjögren’s syndrome, and autoimmune hepatitis.[1][3][6][14][18][21] Background reviews and national health agencies report that autoimmune diseases collectively affect roughly 3–10% of the population, with recent data suggesting rising incidence and prevalence over recent decades.[15][17][18][21][24] Systematic and guideline-level work shows that autoimmune diseases typically result from interactions between genetic susceptibility (e.g., HLA variants, other risk alleles) and environmental exposures (infections, chemicals, diet, drugs, smoking, UV, microbiome) that lead to breakdown of immune tolerance.[1][2][3][7][14][15][18][21][24] Major rheumatology and hepatology guidelines (e.g., for rheumatoid arthritis, spondyloarthropathies, autoimmune hepatitis) emphasize immunomodulatory or immunosuppressive therapy as standard of care, including corticosteroids, conventional disease-modifying antirheumatic drugs, and targeted biologic agents such as TNF inhibitors, with substantial evidence from randomized trials and meta-analyses that these reduce disease activity and prevent damage.[4][5][13][19][22][25]
- Contradicts
- The indexed clinical trials provided (perioperative chemotherapy plus toripalimab for EBV-associated gastric cancer, home caffeine for apnea of prematurity, axitinib with radiotherapy for hepatocellular carcinoma, and antimicrobial photodynamic therapy for dental biofilm) are not autoimmune-focused and therefore do not provide direct evidence about autoimmune disease pathogenesis, prevalence, or standard treatment, limiting their relevance to the claim. Although debates exist around specific environmental triggers or proposed novel therapeutics (such as helminth or schistosome-derived antigens), current evidence is largely preclinical or early-phase and does not yet support broad claims that such approaches are established treatments or “cures” for autoimmune diseases.[7][8] High-quality reviews and guidelines repeatedly state that most autoimmune diseases have no definitive cure and require long-term management, which contradicts any influencer claim that autoimmune diseases are generally curable with simple or single interventions.[11][14][15][17][21][22][23] Evidence on the exact reasons for the rising prevalence is still incomplete and multifactorial, so strong causal claims attributing the increase to one predominant factor (e.g., one chemical, one food type, or a single vaccine) are not supported by systematic epidemiologic reviews.[7][14][15][18][21][24]
- Mainstream view
- Mainstream medical and scientific consensus is that autoimmune diseases are a large, heterogeneous group of chronic disorders in which the immune system mistakenly targets self-antigens, driven by complex interactions of genetic predisposition and environmental factors, and manifesting as organ-specific or systemic inflammation and damage.[1][2][3][4][5][6][14][20][21] There are more than 80 recognised autoimmune diseases, collectively affecting several percent of the population, with incidence and prevalence increasing over recent decades.[14][15][17][18][21][24] For most autoimmune diseases, there is no cure; instead, standard care focuses on early diagnosis, risk stratification, and long-term management using immunomodulatory or immunosuppressive therapies (including biologics and small molecules) to control disease activity, prevent tissue damage, and improve quality of life.[4][5][11][13][19][21][22][23][25] Current guidelines and high-quality reviews emphasise individualized treatment plans, monitoring for adverse effects, and, increasingly, targeted therapies informed by molecular, omics, and epigenetic insights, but they do not support simplistic or universal “reverse autoimmune disease” strategies.[1][3][5][9][10][16][22] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Autoimmune disease”
Rule: 63 P.S. § 601-§ 627 (Chiropractic Practice Act, as summarized by FCLB)
Gloria Hamada is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Diabetes.
Diabetes
- Supports
- High-quality evidence shows that diet and other non-pharmacological strategies are central to both prevention and management of type 2 diabetes, and in some cases can induce remission. [9][16] Umbrella reviews and systematic reviews demonstrate that structured, energy-restricted dietary programs (including very low energy diets and formula-based total diet replacement) can produce substantial weight loss, improved glycaemic control, and diabetes remission in a significant proportion of adults with type 2 diabetes, at least over 6–12 months. [10][13] Multiple randomized-controlled-trial meta-analyses summarized in umbrella reviews indicate that plant-based, Mediterranean, low-carbohydrate (<26% energy), and high-protein diets, when energy-restricted, can improve HbA1c, body weight, triglycerides, and other cardiometabolic markers in people with type 2 diabetes. [12][14] The American College of Lifestyle Medicine expert consensus supports diet as a primary intervention capable of achieving type 2 diabetes remission in some patients, especially when it leads to major weight loss, although this consensus is based on mixed levels of evidence rather than solely high-certainty RCTs. [15] High-quality umbrella and systematic reviews of diet and diabetes incidence show that Mediterranean and DASH-style patterns, and higher intake of whole grains, fiber, low-fat dairy, olive oil, and other nutrient-dense foods, significantly reduce the risk of developing type 2 diabetes, consistent with a strong preventive role of diet. [11] Major guidelines and consensus reports (ADA/EASD) explicitly recognize lifestyle modification (diet, physical activity, weight management) as foundational therapy for type 2 diabetes and formally define “remission” (HbA1c <6. 5% for at least 3 months off glucose-lowering medication), acknowledging that remission is achievable though not guaranteed.
- Contradicts
- Despite strong evidence that intensive dietary and lifestyle interventions can improve glycaemic control and sometimes induce remission, high-quality umbrella reviews highlight that most remission data are limited to around one year, and long-term durability beyond 2 years is uncertain or poorly studied. Evidence comparing specific macronutrient patterns is mixed: meta-analyses of hypocaloric diets for type 2 diabetes do not consistently support any one macronutrient profile (e. [9][10][13] g. , low carbohydrate versus higher carbohydrate) as clearly superior for long-term weight management, and some low-carbohydrate or ketogenic diet remission results come from studies with serious or critical risk of bias and very low certainty. [16] The ADA/EASD consensus views type 2 diabetes as generally chronic and progressive, meaning that while remission is possible in some individuals, most patients will not achieve durable drug-free remission solely through diet, and many will need ongoing pharmacologic therapy in addition to lifestyle change. [15] Umbrella reviews emphasize that diet interventions are beneficial but not curative for the majority; they reduce risk and improve control rather than reliably eliminating the disease, and benefits often decline with weight regain or reduced adherence, indicating that claims of simple or universal dietary cures are not supported by current evidence. [11][12][14]
- Mainstream view
- Mainstream medical and scientific consensus is that type 2 diabetes is a chronic, usually progressive metabolic disease strongly influenced by lifestyle and diet, but not typically “cured”; instead, it can often be well controlled, and in some patients can enter remission, particularly after substantial weight loss and sustained dietary change. [11][14][15][16] Current high-quality evidence and major guidelines agree that healthy, energy-restricted dietary patterns and comprehensive lifestyle interventions are first-line, foundational therapy for prevention and management of type 2 diabetes, but pharmacologic treatment (e. [9] g. , metformin and other glucose-lowering agents) is usually required for many patients to achieve and maintain target glycaemic levels. Diet-based, weight-loss–focused interventions can induce remission in a subset of patients, especially early in the disease course and when significant weight loss is achieved, yet remission is not guaranteed, may be time-limited, and requires ongoing monitoring because vascular and other complication risks may persist. Accordingly, mainstream practice encourages intensive lifestyle modification for all patients with or at risk for type 2 diabetes, while also using medications, and increasingly discussing remission as a realistic but conditional goal rather than a universal outcome. [10][13] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Diabetes”
Rule: 63 P.S. § 601-§ 627
Gloria Hamada is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Digestive issues & leaky gut.
Digestive issues & leaky gut
- Supports
- The core biological concept behind the claim is real: increased intestinal permeability has been documented in inflammatory bowel disease and is addressed in an ESPEN guideline on IBD clinical nutrition . [18][19][20][22][23][24] Reviews of human studies also describe measurable barrier dysfunction in some disease states and note that intestinal permeability can be altered by diet, drugs, infection, and inflammation . [21] A recent meta-analysis of RCTs found that probiotics, synbiotics, and prebiotics can reduce some permeability-related markers, although the certainty was often low or heterogeneous .
- Contradicts
- The broad influencer-style framing is not well supported because “leaky gut syndrome” is not an established standalone diagnosis, and symptoms such as nonspecific digestive issues are not enough to diagnose it. [21][22] Major reviews state that public claims about ‘healthy’ versus ‘leaky’ gut require confirmation before endorsing restrictive diets or other interventions , and earlier expert reviews noted the absence of conclusive human data and no FDA-approved or investigational drugs specifically targeting barrier repair . [24] Mainstream sources also emphasize that intestinal permeability is usually secondary to underlying conditions such as celiac disease, IBD, infection, NSAID injury, or chemotherapy, rather than a generic explanation for digestive complaints . [23] The provided index papers are mostly nutrition guidelines and do not directly establish that “digestive issues” in general are caused by leaky gut . [18][20]
- Mainstream view
- Mainstream medicine recognizes intestinal permeability as a real physiologic phenomenon that can contribute to or reflect certain diseases, especially IBD and celiac-related injury, but it does not recognize “leaky gut syndrome” as a validated catch-all diagnosis for nonspecific digestive symptoms. [21][22][23] The standard approach is to look for specific underlying gastrointestinal or systemic causes and treat those, while the evidence for broad “leaky gut” testing or treatment claims remains limited and inconsistent . [24] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Digestive issues & leaky gut”
Rule: 63 P.S. § 601-§ 627
Gloria Hamada is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure She found it. I suffered from a few bacterias in my intestines wrecking havoc, candida overgrowth, multiple food sensitivities from leaky gut syndrome, a gene that caused severe gluten intolerance and more..
She found it. I suffered from a few bacterias in my intestines wrecking havoc, candida overgrowth, multiple food sensitivities from leaky gut syndrome, a gene that caused severe gluten intolerance and more.
- Supports
- There is evidence that the gut normally harbors bacteria and Candida species, and that dysbiosis (microbial imbalance) can be associated with intestinal inflammation and barrier dysfunction, sometimes described as increased intestinal permeability or “leaky gut. [25][26][27][28][29][30][31] ” Narrative and experimental reviews report that disruption of the intestinal barrier (“leaky gut”) can occur with infections, dysbiosis, diet, and other stressors and is linked to systemic inflammation and allergic disease. [21] Experimental and animal data indicate that gastrointestinal Candida colonization can impair the mucosal barrier and promote sensitization to food antigens, suggesting a plausible mechanistic link between Candida, barrier changes, and food allergy or sensitivity, though this is not firmly established in humans. Some human studies show that gluten exposure increases intestinal permeability, particularly in celiac disease and possibly in non-celiac gluten sensitivity, and that genetic susceptibility (e. g. , HLA-DQ2/DQ8) plays a key role in severe immune-mediated gluten intolerance such as celiac disease. Overall, mainstream academic literature supports that gut dysbiosis, including Candida and bacteria, can contribute to barrier dysfunction and immune activation, and that genetic factors can underlie clinically significant gluten-related disorders, but this support is mainly at the level of mechanistic, observational, or narrative evidence rather than high-quality RCTs definitively linking these mechanisms to the broad constellation of symptoms often claimed by influencers.
- Contradicts
- High-quality evidence does not support the broad, popularized notion of “candida overgrowth” in the intestines as a common cause of multiple nonspecific symptoms, food sensitivities, and generalized illness in otherwise immunocompetent people. [31] Expert reviews emphasize that documented pathogenic gastrointestinal Candida infections are relatively rare, usually occur in severely ill or immunocompromised patients, and that much of the lay discussion around intestinal Candida overgrowth and chronic symptoms is not backed by robust clinical trials or guidelines. [26][27][30] The concept of “leaky gut syndrome” as a distinct, diagnosable syndrome responsible for wide-ranging systemic symptoms is considered hypothetical and controversial; although increased intestinal permeability is a real physiological phenomenon, major medical organizations do not recognize “leaky gut syndrome” as a validated clinical diagnosis, and standardized diagnostic criteria and evidence-based treatments are lacking. [21][28] Evidence linking Candida specifically to leaky gut and then to multiple food sensitivities in humans is weak, relying largely on animal models, in vitro data, and anecdotal or low-quality clinical reports, not large, controlled trials. Similarly, outside established entities like celiac disease and defined non-celiac gluten sensitivity, the idea of a single “gene that causes severe gluten intolerance” explaining broad symptom clusters is oversimplified and not supported by strong evidence; HLA and other genetic factors increase risk but are not deterministic, and severe gluten intolerance without celiac disease remains incompletely understood. Overall, the claim that one practitioner can reliably diagnose “a few bacterias,” Candida overgrowth, leaky gut syndrome, multiple food sensitivities, and a gluten-intolerance gene as the unified cause of complex symptoms goes beyond what current high-quality evidence can support. [25][29]
- Mainstream view
- Mainstream medical and scientific positions are that: (1) the gut contains complex communities of bacteria and fungi, including Candida, and dysbiosis can be associated with disease, but routine clinical testing and treatment for “Candida overgrowth” in otherwise healthy adults is not recommended because robust evidence and guidelines are lacking; (2) increased intestinal permeability is a recognized biological phenomenon that plays a role in specific conditions (e. [25][26][27][28][29][30][31] g. , celiac disease, inflammatory bowel disease, some food allergies), yet “leaky gut syndrome” as marketed in wellness circles is not an accepted diagnosis in major guidelines, and many commercial tests and treatments for it are considered unproven; (3) food allergies and some food intolerances are real and can be influenced by immune mechanisms and gut barrier function, but claims that broad panels of “sensitivities” are caused by Candida or leaky gut are not backed by strong, reproducible clinical trial data; (4) severe gluten intolerance is well established in celiac disease, which has clear genetic associations and diagnostic criteria, and non-celiac gluten sensitivity is recognized but less well defined; however, mainstream experts do not endorse simplistic narratives that a single gene explains all severe gluten reactions outside these conditions. Consequently, while elements of the influencer’s claim (gut microbiota, intestinal permeability, genetic risk for gluten-related disease) reflect real research areas, the overall diagnostic and causal story—multiple bacteria, Candida overgrowth, leaky gut syndrome, widespread food sensitivities, and a “gluten-intolerance gene” all definitively identified as the cause of her symptoms—overstates and extrapolates beyond current high-quality evidence and guideline-based practice. [21] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“She found it. I suffered from a few bacterias in my intestines wrecking havoc, candida overgrowth, multiple food sensitivities from leaky gut syndrome, a gene that caused severe gluten intolerance and more.”
Rule: 63 P.S. § 601-§ 627
Gloria Hamada is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Diagnosing and treating systemic internal diseases (autoimmune, diabetes, cardiovascular) which are outside the musculoskeletal scope of a DC..
Diagnosing and treating systemic internal diseases (autoimmune, diabetes, cardiovascular) which are outside the musculoskeletal scope of a DC.
- Supports
- High-quality evidence shows that diet and other non-pharmacological strategies are central to both prevention and management of type 2 diabetes, and in some cases can induce remission. [9][16] Umbrella reviews and systematic reviews demonstrate that structured, energy-restricted dietary programs (including very low energy diets and formula-based total diet replacement) can produce substantial weight loss, improved glycaemic control, and diabetes remission in a significant proportion of adults with type 2 diabetes, at least over 6–12 months. [10][13] Multiple randomized-controlled-trial meta-analyses summarized in umbrella reviews indicate that plant-based, Mediterranean, low-carbohydrate (<26% energy), and high-protein diets, when energy-restricted, can improve HbA1c, body weight, triglycerides, and other cardiometabolic markers in people with type 2 diabetes. [12][14] The American College of Lifestyle Medicine expert consensus supports diet as a primary intervention capable of achieving type 2 diabetes remission in some patients, especially when it leads to major weight loss, although this consensus is based on mixed levels of evidence rather than solely high-certainty RCTs. [15] High-quality umbrella and systematic reviews of diet and diabetes incidence show that Mediterranean and DASH-style patterns, and higher intake of whole grains, fiber, low-fat dairy, olive oil, and other nutrient-dense foods, significantly reduce the risk of developing type 2 diabetes, consistent with a strong preventive role of diet. [11] Major guidelines and consensus reports (ADA/EASD) explicitly recognize lifestyle modification (diet, physical activity, weight management) as foundational therapy for type 2 diabetes and formally define “remission” (HbA1c <6. 5% for at least 3 months off glucose-lowering medication), acknowledging that remission is achievable though not guaranteed.
- Contradicts
- Despite strong evidence that intensive dietary and lifestyle interventions can improve glycaemic control and sometimes induce remission, high-quality umbrella reviews highlight that most remission data are limited to around one year, and long-term durability beyond 2 years is uncertain or poorly studied. Evidence comparing specific macronutrient patterns is mixed: meta-analyses of hypocaloric diets for type 2 diabetes do not consistently support any one macronutrient profile (e. [9][10][13] g. , low carbohydrate versus higher carbohydrate) as clearly superior for long-term weight management, and some low-carbohydrate or ketogenic diet remission results come from studies with serious or critical risk of bias and very low certainty. [16] The ADA/EASD consensus views type 2 diabetes as generally chronic and progressive, meaning that while remission is possible in some individuals, most patients will not achieve durable drug-free remission solely through diet, and many will need ongoing pharmacologic therapy in addition to lifestyle change. [15] Umbrella reviews emphasize that diet interventions are beneficial but not curative for the majority; they reduce risk and improve control rather than reliably eliminating the disease, and benefits often decline with weight regain or reduced adherence, indicating that claims of simple or universal dietary cures are not supported by current evidence. [11][12][14]
- Mainstream view
- Mainstream medical and scientific consensus is that type 2 diabetes is a chronic, usually progressive metabolic disease strongly influenced by lifestyle and diet, but not typically “cured”; instead, it can often be well controlled, and in some patients can enter remission, particularly after substantial weight loss and sustained dietary change. [11][14][15][16] Current high-quality evidence and major guidelines agree that healthy, energy-restricted dietary patterns and comprehensive lifestyle interventions are first-line, foundational therapy for prevention and management of type 2 diabetes, but pharmacologic treatment (e. [9] g. , metformin and other glucose-lowering agents) is usually required for many patients to achieve and maintain target glycaemic levels. Diet-based, weight-loss–focused interventions can induce remission in a subset of patients, especially early in the disease course and when significant weight loss is achieved, yet remission is not guaranteed, may be time-limited, and requires ongoing monitoring because vascular and other complication risks may persist. Accordingly, mainstream practice encourages intensive lifestyle modification for all patients with or at risk for type 2 diabetes, while also using medications, and increasingly discussing remission as a realistic but conditional goal rather than a universal outcome. [10][13] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Diabetes”
Rule: 63 P.S. § 601-§ 627
Gloria Hamada is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Treatment of Autoimmune Disease, Diabetes, Cardiovascular Disease.
Treatment of Autoimmune Disease, Diabetes, Cardiovascular Disease
- Supports
- High-quality evidence shows that diet and other non-pharmacological strategies are central to both prevention and management of type 2 diabetes, and in some cases can induce remission. [9][16] Umbrella reviews and systematic reviews demonstrate that structured, energy-restricted dietary programs (including very low energy diets and formula-based total diet replacement) can produce substantial weight loss, improved glycaemic control, and diabetes remission in a significant proportion of adults with type 2 diabetes, at least over 6–12 months. [10][13] Multiple randomized-controlled-trial meta-analyses summarized in umbrella reviews indicate that plant-based, Mediterranean, low-carbohydrate (<26% energy), and high-protein diets, when energy-restricted, can improve HbA1c, body weight, triglycerides, and other cardiometabolic markers in people with type 2 diabetes. [12][14] The American College of Lifestyle Medicine expert consensus supports diet as a primary intervention capable of achieving type 2 diabetes remission in some patients, especially when it leads to major weight loss, although this consensus is based on mixed levels of evidence rather than solely high-certainty RCTs. [15] High-quality umbrella and systematic reviews of diet and diabetes incidence show that Mediterranean and DASH-style patterns, and higher intake of whole grains, fiber, low-fat dairy, olive oil, and other nutrient-dense foods, significantly reduce the risk of developing type 2 diabetes, consistent with a strong preventive role of diet. [11] Major guidelines and consensus reports (ADA/EASD) explicitly recognize lifestyle modification (diet, physical activity, weight management) as foundational therapy for type 2 diabetes and formally define “remission” (HbA1c <6. 5% for at least 3 months off glucose-lowering medication), acknowledging that remission is achievable though not guaranteed.
- Contradicts
- Despite strong evidence that intensive dietary and lifestyle interventions can improve glycaemic control and sometimes induce remission, high-quality umbrella reviews highlight that most remission data are limited to around one year, and long-term durability beyond 2 years is uncertain or poorly studied. Evidence comparing specific macronutrient patterns is mixed: meta-analyses of hypocaloric diets for type 2 diabetes do not consistently support any one macronutrient profile (e. [9][10][13] g. , low carbohydrate versus higher carbohydrate) as clearly superior for long-term weight management, and some low-carbohydrate or ketogenic diet remission results come from studies with serious or critical risk of bias and very low certainty. [16] The ADA/EASD consensus views type 2 diabetes as generally chronic and progressive, meaning that while remission is possible in some individuals, most patients will not achieve durable drug-free remission solely through diet, and many will need ongoing pharmacologic therapy in addition to lifestyle change. [15] Umbrella reviews emphasize that diet interventions are beneficial but not curative for the majority; they reduce risk and improve control rather than reliably eliminating the disease, and benefits often decline with weight regain or reduced adherence, indicating that claims of simple or universal dietary cures are not supported by current evidence. [11][12][14]
- Mainstream view
- Mainstream medical and scientific consensus is that type 2 diabetes is a chronic, usually progressive metabolic disease strongly influenced by lifestyle and diet, but not typically “cured”; instead, it can often be well controlled, and in some patients can enter remission, particularly after substantial weight loss and sustained dietary change. [11][14][15][16] Current high-quality evidence and major guidelines agree that healthy, energy-restricted dietary patterns and comprehensive lifestyle interventions are first-line, foundational therapy for prevention and management of type 2 diabetes, but pharmacologic treatment (e. [9] g. , metformin and other glucose-lowering agents) is usually required for many patients to achieve and maintain target glycaemic levels. Diet-based, weight-loss–focused interventions can induce remission in a subset of patients, especially early in the disease course and when significant weight loss is achieved, yet remission is not guaranteed, may be time-limited, and requires ongoing monitoring because vascular and other complication risks may persist. Accordingly, mainstream practice encourages intensive lifestyle modification for all patients with or at risk for type 2 diabetes, while also using medications, and increasingly discussing remission as a realistic but conditional goal rather than a universal outcome. [10][13] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Autoimmune disease”
Rule: 63 P.S. § 601-§ 627
Gloria Hamada is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Cardiovascular.
Cardiovascular
- Supports
- The very broad influencer claim of “Cardiovascular” cannot be directly evaluated, but major high‑quality evidence supports several core principles that underlie cardiovascular risk and management. Guideline‑driven management of hypertension is strongly supported by large randomized trials and synthesized in contemporary evidence‑based reviews, which show that treating elevated blood pressure reduces cardiovascular events and all‑cause mortality. [17] Hypertension guidelines emphasize accurate blood pressure measurement, risk stratification, lifestyle changes, and pharmacologic therapy to achieve target blood pressure levels, based on extensive RCT and meta‑analysis data linking lower blood pressure to reduced coronary heart disease, heart failure, and stroke. [18] Umbrella reviews and meta‑analyses integrating hundreds of cohort studies and Mendelian randomization analyses show that increased adiposity (often measured by body mass index) is associated with higher risks of coronary heart disease, heart failure, atrial fibrillation, stroke, hypertension, venous thromboembolism, and other cardiovascular outcomes, and that obesity is likely a causal risk factor for many of these outcomes. [32][34][35] A prior systematic review and meta‑analysis similarly found obesity to be associated with coronary artery disease and type 2 diabetes, reinforcing adiposity as a major cardiovascular risk factor. Decades of epidemiology and preventive cardiology research, including Framingham‑type cohorts and subsequent systematic reviews, have established traditional cardiovascular risk factors—hypertension, dyslipidemia, diabetes, smoking, obesity, physical inactivity, and family history—as key modifiable determinants of cardiovascular disease risk, and guideline documents operationalize these for prevention and treatment. [36][37]
- Contradicts
- Because the influencer’s claim is vague (“Cardiovascular”), the main way high‑quality evidence could contradict it would be if they implied that cardiovascular disease is unrelated to established modifiable risk factors or that guideline‑based management of hypertension and obesity has no impact on cardiovascular outcomes. [17][34][35][36] Modern hypertension guidelines, drawing on extensive randomized controlled trial evidence, explicitly state that blood pressure control reduces cardiovascular events and mortality, so any claim denying the importance of blood pressure control would conflict with this evidence. [18] Umbrella reviews and Mendelian randomization analyses show that higher adiposity causally increases risk for multiple cardiovascular outcomes (e. [32] g. , coronary heart disease, heart failure, atrial fibrillation, hypertension), so a claim that adiposity has no cardiovascular impact or that weight management is irrelevant would be inconsistent with the available data. Conversely, if the influencer suggested that a single factor fully explains cardiovascular disease risk while dismissing blood pressure, lipids, diabetes, lifestyle, and adiposity, that would also be at odds with the multifactorial risk framework supported by large cohort studies and guideline syntheses. Evidence is weaker or more nuanced for some endpoints—for example, Mendelian randomization analyses in the adiposity umbrella review did not demonstrate a clear causal effect of obesity on all‑cause mortality or some stroke subtypes, indicating that strong statements that obesity directly causes every cardiovascular outcome may overreach the data.
- Mainstream view
- The mainstream medical and scientific position is that cardiovascular disease risk is multifactorial, with strong, causal contributions from modifiable risk factors such as hypertension, dyslipidemia, diabetes, smoking, obesity/adiposity, poor diet, and physical inactivity, as well as nonmodifiable factors like age, sex, and genetic predisposition. [36] Evidence‑based guidelines recommend systematic cardiovascular risk assessment and guideline‑driven management of hypertension, lifestyle modification, and where appropriate pharmacotherapy (such as antihypertensive and lipid‑lowering agents) to reduce the incidence of coronary heart disease, stroke, heart failure, and other cardiovascular outcomes. [17][18][35] High‑quality syntheses of observational and Mendelian randomization studies support adiposity as an important—and often causal—risk factor for many cardiovascular diseases, reinforcing mainstream public health recommendations to prevent and manage obesity to reduce cardiovascular risk. [32][34] Overall, mainstream practice emphasizes integrated risk factor control rather than focusing on a single cause or ignoring established determinants of cardiovascular disease. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Cardiovascular”
Rule: 63 P.S. § 601-§ 627
Gloria Hamada is not licensed or approved by state chiropractic licensing board to advertise finds the root cause of your symptoms and illness as within their scope of practice.
finds the root cause of your symptoms and illness
No specific health claims of theirs were cross-checked against the literature.
“finds the root cause of your symptoms and illness”
Rule: State Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Gloria Hamada is not licensed or approved by state chiropractic licensing board to diagnose, treat, or cure Fatigue.
Fatigue
No specific health claims of theirs were cross-checked against the literature.
“Fatigue”
Rule: State Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Manipulation
False Authority
transcript · cited
A chiropractor (DC) uses the title 'Dr.' and 'Functional Medicine Certified Practitioner' to imply broad medical authority equivalent to an MD/DO, despite their license being limited to musculoskeletal care. Likely motive: To attract patients with systemic diseases (autoimmune, diabetes) who would otherwise seek an MD/DO, by borrowing the authority of a narrow credential.
“Functional Medicine Certified Practitioner and Board Certified Clinical Nutritionist, Dr. Gloria Hamada”
Lab Test Upsell
transcript · cited
The practitioner promotes expensive 'specialty' labs (often functional medicine panels) that are not standard of care, framing them as necessary for 'root cause' analysis. Likely motive: To generate revenue from high-cost lab tests that insurance typically denies, while positioning the practitioner as the sole interpreter of 'complex' data.
“Dr. Gloria uses specialty laboratories for the majority of testing that are only available to healthcare professionals.”
Fear Mongering
transcript · cited
The practitioner frames insurance as an adversary that limits care and prevents patients from getting 'well,' creating fear of the standard healthcare system. Likely motive: To justify the cash-only model and high costs of functional medicine by portraying it as the only path to true health.
“Insurance companies decide how long and what type of care physicians can provide to their patients. This is why a growing number of physicians have moved away from accepting insurance.”
Sales Funnel Motive
transcript · cited
The practitioner directs patients to a proprietary online dispensary for supplements, creating a direct revenue stream from patient purchases. Likely motive: To monetize patient care through supplement sales, often at inflated prices, without a clear material-connection disclosure.
“Dr. Gloria recommends purchasing supplements through her online dispensary to ensure you are receiving them from a reliable source.”
Undisclosed Compensation
transcript · cited
The content promotes an online dispensary and specialty labs without an explicit #ad, sponsored, or paid partnership disclosure, hiding the financial incentive. Likely motive: To avoid FTC scrutiny while profiting from the sale of products and tests to patients.
“Dr. Gloria recommends purchasing supplements through her online dispensary”
Commerce & grift map
The grift flows from fear-based content about insurance denying care -> expensive 'specialty' lab tests to find 'root causes' -> mandatory purchase of supplements from the practitioner's online dispensary. The cash-only model avoids insurance scrutiny while maximizing revenue from high-margin tests and products. The missing disclosure hides the financial incentive behind the 'reliable source' claim.
No FTC-style compensation disclosure
compensationDisclosures · scan
The practitioner directs patients to an online dispensary for supplements, likely earning a markup or commission on sales.
dispensing_markup
Host self-funnel around guest content
guestCollaboration · selfFunnel
Host booking/consult links: https://www.hamadahealth.com/contact, https://www.hamadahealth.com/about
Supplements pitched
- Hamada Health Online Dispensary
“Dr. Gloria recommends purchasing supplements through her online dispensary to ensure you are receiving them from a reliable source.”
Labs pitched
- Specialty Laboratory Testing
“Dr. Gloria uses specialty laboratories for the majority of testing that are only available to healthcare professionals.”
How the money flows
- In-office dispensing markupUndisclosed The practitioner directs patients to an online dispensary for supplements, likely earning a markup or commission on sales. “Dr. Gloria recommends purchasing supplements through her online dispensary”
“Dr. Gloria recommends purchasing supplements through her online dispensary”
- Lab testing referralUndisclosed The practitioner promotes 'specialty laboratories' for testing, likely receiving a referral fee or discount from the lab vendor. “Dr. Gloria uses specialty laboratories for the majority of testing”
“Dr. Gloria uses specialty laboratories for the majority of testing”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: Chiropractor, DR, DOCTOR
A licensed chiropractor (Chiropractor) uses the title 'Dr.' and certifications in nutrition and functional medicine to imply broad medical competence for diagnosing and treating systemic diseases like diabetes and autoimmune conditions, which is outside the scope of a chiropractic license.
- DC, Doctor of Chiropractic
A state-regulated professional license focused on the musculoskeletal and nervous systems, primarily through spinal adjustment. It is NOT a license for general internal medicine, prescribing drugs, or managing systemic diseases like diabetes or cancer.
State chiropractic boards typically limit scope to evaluation/treatment of musculoskeletal conditions. Diagnosing/treating systemic internal diseases (autoimmune, diabetes, cardiovascular) is out of scope.
“Functional Medicine Certified Practitioner, Board Certified Clinical Nutritionist and Licensed Doctor of Chiropractic”
Permitted scope vs advertised
state chiropractic licensing board · Confidence: medium
In Pennsylvania, chiropractors diagnose only to determine the nature and appropriateness of chiropractic treatment, focusing on the vertebral column, other articulations, and related neuro-musculoskeletal conditions, and may provide nutritional counseling but may not use drugs, surgery, or practice obstetrics or gynecology.[6] Their scope centers on spinal and joint adjustment, related adjunctive procedures, and non-pharmacologic patient care aimed at restoration and maintenance of health within the musculoskeletal and nervous systems.[6]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
14 of 14 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Autoimmune disease Rule: 63 P.S. § 601-§ 627 (Chiropractic Practice Act, as summarized by FCLB) Diagnosing autoimmune disease is a diagnosis of systemic internal disease beyond the neuro-musculoskeletal focus and beyond diagnosis solely to determine appropriateness of chiropractic treatment. | Outside scope |
| Listed service Diabetes Rule: 63 P.S. § 601-§ 627 Diabetes is an endocrine/metabolic systemic disease, and diagnosing it exceeds chiropractic diagnosis limited to determining the nature and appropriateness of chiropractic treatment for neuro-musculoskeletal conditions. | Outside scope |
| Listed service Digestive issues & leaky gut Rule: 63 P.S. § 601-§ 627 Diagnosing and managing digestive disorders and "leaky gut" constitutes internal systemic disease management not affirmatively authorized within the musculoskeletal and neuro-musculoskeletal chiropractic focus. | Outside scope |
| She found it. I suffered from a few bacterias in my intestines wrecking havoc, candida overgrowth, multiple food sensitivities from leaky gut syndrome, a gene that caused severe gluten intolerance and more. Rule: 63 P.S. § 601-§ 627 Diagnosing intestinal bacterial and candida overgrowth, leaky gut syndrome, genetic gluten intolerance, and multiple food sensitivities represents systemic and genetic disease diagnosis beyond chiropractic’s permitted diagnostic role tied to chiropractic treatment. | Outside scope |
| Diagnosing and treating systemic internal diseases (autoimmune, diabetes, cardiovascular) which are outside the musculoskeletal scope of a DC. Rule: 63 P.S. § 601-§ 627 Systemic internal disease diagnosis and treatment (autoimmune, diabetes, cardiovascular) are not affirmatively authorized and exceed the neuro-musculoskeletal and chiropractic-treatment-focused diagnostic scope. | Outside scope |
| Diagnosing bacterial and candida overgrowth in the intestines as a root cause of illness. Rule: 63 P.S. § 601-§ 627 Identifying intestinal bacterial and candida overgrowth as root causes of systemic illness goes beyond musculoskeletal and nervous system conditions and the limited diagnostic authority tied to chiropractic care. | Outside scope |
| Treatment of Autoimmune Disease, Diabetes, Cardiovascular Disease Rule: 63 P.S. § 601-§ 627 Treating autoimmune, diabetic, and cardiovascular diseases constitutes management of systemic internal diseases that are not affirmatively permitted within the chiropractic practice focused on articulations and the neuro-musculoskeletal system. | Outside scope |
| Listed service Cardiovascular Rule: 63 P.S. § 601-§ 627 Diagnosing or managing cardiovascular disease involves systemic internal medicine outside the explicitly musculoskeletal and nervous system-focused chiropractic scope. | Outside scope |
| finds the root cause of your symptoms and illness Rule: State Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Fatigue Rule: State Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Finding 'root causes' of systemic illness, a functional medicine claim not supported by chiropractic scope. Rule: 63 P.S. § 601-§ 627 Functional medicine-style investigation of systemic root causes of illness represents broad primary-care diagnostic practice not affirmatively authorized for chiropractors whose diagnostic role is limited to chiropractic treatment decisions. | Outside scope |
| Advising on nutritional needs relative to prescribed medications, which implies drug management. Rule: 63 P.S. § 601-§ 627 While nutritional counseling is permitted, advising relative to prescribed medications implies drug management, and the statute expressly excludes the use of drugs or surgery from the chiropractic scope. | Outside scope |
| Functional Medicine Root Cause Analysis Rule: 63 P.S. § 601-§ 627 Offering functional medicine root cause analysis entails comprehensive systemic disease assessment beyond diagnosis solely for determining appropriateness of chiropractic treatment within the neuro-musculoskeletal focus. | Outside scope |
| Specialty Laboratory Testing for Root Causes Rule: State Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
Sources: Federation of Chiropractic Licensing Boards – Pennsylvania scope summary (quoting Chiropractic Practice Act), Commonwealth of Pennsylvania – State Board of Chiropractic (official), [PDF] Arkansas State Board of Chiropractic Examiners Statutes and Rules (official), [PDF] Rules and Regulations - California Board of Chiropractic Examiners (official)
Disclaimer hypocrisy
Dr. Hamada hides behind a 'wellness self-care program' disclaimer while actively diagnosing systemic diseases, prescribing nutritional interventions for medications, and listing conditions like diabetes and autoimmune disease as treatable. It's the classic 'not medical advice' shield used to practice medicine without a license.
When the service is also outside their license
This pattern gets sharper when the service routed to your FSA or HSA also sits outside the practitioner's licensed scope. A provider advertising to diagnose or treat conditions their state board does not authorize is already operating past the edge of their license. Pair that with a cash-pay, FSA or HSA funded model that keeps the work away from any insurer or government program, and there is no claims reviewer, no audit trail, and no payer left to ask whether the care was appropriate or even within the provider's remit. The tax advantaged dollars do the paying, the patient carries the substantiation, and the scope question never reaches anyone with the authority to raise it.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (hamadahealth.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission xAGWCX7a1w2fbTxy9pqAp
Fight disinformation
Log a public thread where Gloria Hamada is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Gloria Hamada's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/xAGWCX7a1w2fbTxy9pqAp. White-coat charisma isn't evidence.
Full DTMB scan on Gloria Hamada: https://drtrustmebro.com/analyze/xAGWCX7a1w2fbTxy9pqAp
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so Gloria Hamada can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Gloria Hamada, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Gloria Hamada. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: 5UrEpX460I9Nm6ivMprmg
- Wall entry: /influencer/5UrEpX460I9Nm6ivMprmg
- Analysis ID: xAGWCX7a1w2fbTxy9pqAp
- Source: https://hamadahealth.com
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Pathogenesis of autoimmune disease
- [2] Autoimmunity as a Predisposition for Infectious Diseases
- [3] Autoimmune disease: a view of epigenetics and therapeutic targeting
- [4] Theory, Targets and Therapy in Rheumatic Diseases
- [5] Treating Human Autoimmunity: Current Practice and Future Prospects
- [6] Special Issue “Advances in Molecular Research on Autoimmune Diseases”
- [7] Autoimmunity and the Gut
- [8] Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
- [9] Effectiveness of non-pharmacological strategies in the management of type 2 diabetes in primary care: a protocol for a systematic review and network meta-analysis.
- [10] Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.
- [11] Preventive Role of Diet Interventions and Dietary Factors in Type 2 Diabetes Mellitus: An Umbrella Review.
- [12] Ultra-processed food consumption and human health: an umbrella review of systematic reviews with meta-analyses.
- [13] Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission
- [14] Diet in the management of type 2 diabetes: umbrella review of systematic reviews with meta-analyses of randomised controlled trials
- [15] Dietary Interventions to Treat Type 2 Diabetes in Adults with a Goal of Remission: An Expert Consensus Statement from the American College of Lifestyle Medicine
- [16] Physiological and psychological determinants of long‐term diet‐induced type 2 diabetes (T2DM) remission: A narrative review
- [17] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [18] ASPEN-FELANPE Clinical Guidelines.
- [19] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
- [20] When Is Parenteral Nutrition Appropriate?
- [21] Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
- [22] Leaky gut: mechanisms, measurement and clinical implications in humans
- [23] Intestinal permeability – a new target for disease prevention and therapy
- [24] Overview of the Importance of Biotics in Gut Barrier Integrity
- [25] How Gut Bacterial Dysbiosis Can Promote Candida albicans Overgrowth during Colonic Inflammation
- [26] Candida spp. in Human Intestinal Health and Disease: More than a Gut Feeling
- [27] Unveiling Candida albicans intestinal carriage in healthy volunteers: the role of micro- and mycobiota, diet, host genetics and immune response
- [28] Yeasts in the gut: from commensals to infectious agents.
- [29] The interplay between gut bacteria and the yeast Candida albicans
- [30] Escherichia coli Nissle 1917 Antagonizes Candida albicans Growth and Protects Intestinal Cells from C. albicans-Mediated Damage
- [31] Augmented Enterocyte Damage During Candida albicans and Proteus mirabilis Coinfection
- [32] Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies.
- [33] AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review.
- [34] Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings
- [35] Pathways leading to prevention of fatal and non-fatal cardiovascular disease: An interaction model on 15 years population-based cohort study
- [36] The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease
- [37] Sixty Years of Preventive Cardiology: A Framingham Perspective